Black Diamond Therapeutics (BDTX) Q2 2026 Earnings

13MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.27
-0.23
-0.19
-0.15

Details

Expected EPS
-0.185
Actual EPS
N/A
Surprise EPS
0.19
Surprise Percent
+100%

Description

Black Diamond Therapeutics (BDTX) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts